ArticleAntibiotics (Basel, Switzerland)2023
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible
Open access · goldAbstract read
In one paragraph
Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 12 citations in OpenAlex.
- Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis.Pharmaceutics · 2026Review
- Analysis of the efficacy and safety of intravenous injection combined with nebulized inhalation of polymyxin E sodium methanesulfonate in the treatment of carbapenem resistant gram-negative bacterial infections in the lungs.Frontiers in cellular and infection microbiology · 2026Observational
- Colistin Sulfate-Based Combination Therapy for Infections Caused by Carbapenem-Resistant Organisms in Intensive Care Units: A Multicenter, Prospective, Observational Clinical Trial.Infectious diseases and therapy · 2025Article
- Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists.Critical care (London, England) · 2025Article
- Nebulized Antibiotics for Preventing and Treating Gram-Negative Respiratory Infections in Critically Ill Patients: An Overview of Reviews.Antibiotics (Basel, Switzerland) · 2025Review
- Analysis and comparison of adverse events of colistin administered by different routes based on the FAERS database.Scientific reports · 2025Article
- High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy.Annals of intensive care · 2024Article
- Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due toAntibiotics (Basel, Switzerland) · 2024Article
- Co-Administration of High-Dose Nebulized Colistin forAntibiotics (Basel, Switzerland) · 2024Article
- Cefiderocol-containing regimens for the treatment of carbapenem-resistantJAC-antimicrobial resistance · 2023Article
- High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review.Microorganisms · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 2 institutions in 1 country.
Gennaro De PascaleDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Gabriele PintaudiDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Lucia LisiSection of Pharmcology, Department of Healthcare Surveillance and Bioethics,Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli IRCCS,L.go A. Gemelli 8, 00168 Rome, Italy.
Flavio De MaioDipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Salvatore Lucio CutuliDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Eloisa Sofia TanzarellaDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Simone CarelliDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Gianmarco LombardiDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Melania CesaranoDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0003-0944-0101
Veronica GennenziDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Gabriella Maria Pia CiottiSection of Pharmcology, Department of Healthcare Surveillance and Bioethics,Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli IRCCS,L.go A. Gemelli 8, 00168 Rome, Italy.
Domenico Luca GriecoDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Brunella PosteraroDipartimento di Scienze Biotecnologiche di base Cliniche Intensivologiche e Perioperatorie,Universita' Cattolica del Sacro Cuore, Rome, L.go F. Vito 1, 00168 Rome, Italy.
Maurizio SanguinettiDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Pierluigi NavarraSection of Pharmcology, Department of Healthcare Surveillance and Bioethics,Catholic University Medical School, Fondazione Policlinico Universitario A. Gemelli IRCCS,L.go A. Gemelli 8, 00168 Rome, Italy.
Massimo AntonelliDipartimento di Scienze Dell'emergenza, Anestesiologiche e Della Rianimazione,Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168 Rome, Italy.
Agostino Gemelli University Polyclinic · ITUniversità Cattolica del Sacro Cuore · IT
Funding
Italian Ministry for University and Scientific Research GR-2018-12367375
Abstract
(1) Background: Colistin-only susceptible (COS)
Indexed as
Acinetobacter baumanniicolistinnebulizationventilator-associated pneumonia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.